HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HighTower Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$1K	–	2357
2019 Q4	$1K	Buy	+1,000	New	+$112K	﹤0.01%	2262
2019 Q2	–	Sell	-500	Closed	-$1K	–	2444
2019 Q1	$1K	Buy	+500	New	+$54.8K	﹤0.01%	2275
2017 Q1	–	Sell	-48,000	Closed	-$4K	–	2122
2016 Q4	$4K	Buy	+48,000	New	+$4.37M	﹤0.01%	1901
2014 Q2	–	Sell	-1,500	Closed	-$8K	–	1654
2014 Q1	$8K	Buy	+1,500	New	+$125K	﹤0.01%	1530

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

HighTower Advisors's IBB Position: Q2 2026 in Review

HighTower Advisors reduced its iShares Biotechnology ETF (IBB) stake by 35% in Q2 2026, selling an estimated $4.28M and leaving 46,004 shares worth $8.75M. The position accounts for 0.01% of the portfolio, ranked #988.

HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $13M in Q1 2019. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

HighTower Advisors held 46,004 shares of iShares Biotechnology ETF worth $8.75M as of Q2 2026.
HighTower Advisors sold 24,900 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.28M.
iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #988 holding.
HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.